Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

IL-10 antibody (Biotin)

IL10 Reactivity: Human, Virus WB, ELISA Host: Rat Monoclonal JES3 Biotin
Catalog No. ABIN2689726
  • Target See all IL-10 (IL10) Antibodies
    IL-10 (IL10) (Interleukin 10 (IL10))
    Reactivity
    • 137
    • 83
    • 49
    • 19
    • 17
    • 11
    • 8
    • 7
    • 6
    • 5
    • 4
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Virus
    Host
    • 125
    • 62
    • 50
    • 4
    • 3
    • 1
    Rat
    Clonality
    • 128
    • 111
    • 1
    Monoclonal
    Conjugate
    • 158
    • 30
    • 12
    • 9
    • 6
    • 5
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    This IL-10 antibody is conjugated to Biotin
    Application
    • 168
    • 115
    • 79
    • 53
    • 40
    • 27
    • 23
    • 19
    • 17
    • 15
    • 14
    • 14
    • 13
    • 13
    • 12
    • 8
    • 7
    • 6
    • 4
    • 4
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Brand
    BD Pharmingen™
    Characteristics
    The JES3-12G8 antibody reacts with human interleukin-10 (IL-10) and viral IL-10. The immunogen used to generate the JES3-12G8 hybridoma was human IL-10. This is a neutralizing antibody. This antibody is routinely tested by ELISA detection. Other applications were tested during antibody development only or reported in the literature.

    BD Pharmingen™ Biotin Anti-Human and Viral IL-10 - Biotin - Clone JES3-12G8 - Isotype Rat IgG2a - Reactivity Hu, Vir - 0.5 mg
    Purification
    The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
    Immunogen
    Human IL-10
    Clone
    JES3
    Isotype
    IgG2a
    Top Product
    Discover our top product IL10 Primary Antibody
  • Application Notes
    Optimal working dilution should be determined by the investigator.
    Restrictions
    For Research Use only
  • Concentration
    0.5 mg/mL
    Buffer
    Aqueous buffered solution containing protein stabilizer and ≤0.09 % sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handling Advice
    The antibody was conjugated with biotin under optimum conditions, and unreacted biotin was removed.
    Storage
    4 °C
    Storage Comment
    Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
  • Burdin, Péronne, Banchereau, Rousset: "Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10." in: The Journal of experimental medicine, Vol. 177, Issue 2, pp. 295-304, (1993) (PubMed).

    Abrams, Roncarolo, Yssel, Andersson, Gleich, Silver: "Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples." in: Immunological reviews, Vol. 127, Issue 9-10, pp. 5-24, (1992) (PubMed).

    Gotlieb, Abrams, Watson, Velu, Berek, Martínez-Maza: "Presence of interleukin 10 (IL-10) in the ascites of patients with ovarian and other intra-abdominal cancers." in: Cytokine, Vol. 4, Issue 5, pp. 385-90, (1992) (PubMed).

    Yssel, De Waal Malefyt, Roncarolo, Abrams, Lahesmaa, Spits, de Vries: "IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 149, Issue 7, pp. 2378-84, (1992) (PubMed).

  • Target
    IL-10 (IL10) (Interleukin 10 (IL10))
    Alternative Name
    IL-10 (IL10 Products)
    Synonyms
    CSIF antibody, GVHDS antibody, IL-10 antibody, IL10A antibody, TGIF antibody, Il-10 antibody, IL10X antibody, interleukin 10 antibody, IL10 antibody, Il10 antibody
    Pathways
    Cellular Response to Molecule of Bacterial Origin, Regulation of Leukocyte Mediated Immunity, Production of Molecular Mediator of Immune Response, Maintenance of Protein Location, Cancer Immune Checkpoints
You are here:
Support